Kezar Life Sciences Files 2024 10-K
Ticker: KZR · Form: 10-K · Filed: Mar 25, 2025 · CIK: 1645666
| Field | Detail |
|---|---|
| Company | Kezar Life Sciences, INC. (KZR) |
| Form Type | 10-K |
| Filed Date | Mar 25, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-K, annual-report, pharmaceuticals
TL;DR
Kezar Life Sciences dropped its 2024 10-K. Full financials out.
AI Summary
Kezar Life Sciences, Inc. filed its 2024 10-K on March 25, 2025, reporting its financial performance for the fiscal year ending December 31, 2024. The company, based in South San Francisco, CA, operates in the pharmaceutical preparations sector. Key financial data and operational details for 2024, 2023, and 2022 are presented within the filing.
Why It Matters
This filing provides investors and stakeholders with a comprehensive overview of Kezar Life Sciences' financial health, strategic direction, and risk factors for the fiscal year 2024, enabling informed investment decisions.
Risk Assessment
Risk Level: medium — As a pharmaceutical company, Kezar Life Sciences faces inherent risks related to drug development, regulatory approvals, and market competition.
Key Numbers
- 2024 — Fiscal Year (Reporting period for the 10-K)
- 2023 — Fiscal Year (Prior year for comparison)
- 2022 — Fiscal Year (Earlier year for trend analysis)
Key Players & Entities
- Kezar Life Sciences, Inc. (company) — Filer of the 10-K
- 2024-12-31 (date) — Fiscal year end
- 2025-03-25 (date) — Filing date
- South San Francisco, CA (location) — Company headquarters
- Pharmaceutical Preparations (industry) — Company's SIC code
FAQ
What were Kezar Life Sciences' total revenues for the fiscal year ended December 31, 2024?
The provided text does not contain specific revenue figures for the fiscal year ended December 31, 2024.
What is Kezar Life Sciences' primary business activity?
Kezar Life Sciences, Inc. is classified under the Standard Industrial Classification code 2834, which corresponds to Pharmaceutical Preparations.
When was this 10-K filing submitted to the SEC?
This 10-K filing was submitted to the SEC on March 25, 2025.
Where is Kezar Life Sciences headquartered?
Kezar Life Sciences, Inc. is headquartered at 4000 Shoreline Court, Suite 300, South San Francisco, CA 94080.
What is the SEC file number for Kezar Life Sciences?
The SEC file number for Kezar Life Sciences is 001-38542.
Filing Details
This Form 10-K (Form 10-K) was filed with the SEC on March 25, 2025 regarding Kezar Life Sciences, Inc. (KZR).